18 Mar 2016 13:07
18 March 2016
Toumaz Limited
Block Listing Update
Pursuant to AIM Rule 29 and Schedule 6 of the AIM Rules for Companies Toumaz Ltd makes the following update on its block listing:
Name of applicant | Toumaz Ltd. |
Name of Schemes | Block Scheme for · Toumaz EMI Scheme. · Toumaz Unapproved Scheme. · Toumaz Unapproved Scheme 2012. |
Period of return | From19th September 2015 - 18th March 2016 |
Balance of unallotted securities under scheme(s) from previous return:
| 44,530,828 ORD 0.25p Shares. |
The amount by which the block scheme(s) has been increased since the date of the last return(if any increase has been applied for):
| N/A |
Less: Number of securities issued/Lapsed under scheme(s) during period.
| 4,759,026 ORD 0.25p Shares. |
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 39,771,802. ORD 0.25p Shares.
|
Enquiries:
Toumaz Limited | +44 (0) 207 391 0630 |
Anthony Sethill, Chief Executive Officer | |
Jonathan Apps, Chief Financial Officer | |
Peel Hunt LLP (Nominated Adviser and Broker) | +44 (0) 207 418 8900 |
Richard Kauffer/Euan Brown | |
Instinctif Partners | +44 (0) 207 457 2020 |
Adrian Duffield/Chantal Woolcock |
About Toumaz (www.toumaz.com)
Toumaz Limited is a pioneer in low-power, wireless semiconductor and software technologies for healthcare and consumer audio. The company has two divisions, Sensium Healthcare and Frontier Silicon. Sensium Healthcare develops wireless solutions for patient monitoring. Frontier Silicon provides chips, modules and software for digital radio and connected audio devices.